Lonewolf1
6 minutes ago
APLT's strategy is to present to the FDA in Q1 of 2025 their results style="caret-color: rgb(35, 42, 49); color: rgba(35, 42, 49, 1); font-family: YahooSans-Regular, sans-serif; font-size: 17px; background-color: rgba(255, 255, 255, 1)"Galactosemia, SORD Deficiency, and PMM2-CDG. The company is al
AJH92
10 minutes ago
Share Structure - Updated February 8, 2025
Transfer Agent Verified
No change - no dilution
Authorized Shares: 2,400,000,000
Outstanding Shares: 2,115,876,871
Restricted: 186,002,437
Unrestricted: 1,929,874,434